News
RadioLIVE: CAR-T cell therapy with Dr Rob Weinkove
Dr Rob Weinkove, clinical research fellow and clinical director of the CAR-T cell pro...
Scope 65 - An unexpected find: new pathways to target hookwo...
In the course of researching asthma, Malaghan scientists have identified a new ta...
Scope 65 - Maurice Capstick Scholar Award recipient: Joshua ...
Congratulations to Malaghan Institute PhD student Joshua Lange for receiving the ...
Scope 65 - Great New Zealand Trek 2018: Stage 13 completed
More than 400 participants and support crew descended on the picturesque Central ...
Scope 65 - ‘Seahorse’ fuelling next stage of cancer cell met...
The Malaghan Institute has recently acquired a new piece of technology that allow...
Scope 65 - Our people: Dr Katherine Woods
The Malaghan Institute welcomed the talented Dr Katherine Woods to our Translatio...
Scope 65 - Malaghan Institute microscopy photo competition w...
Each year, the Malaghan Institute runs an in-house competition celebrating the am...
Scope 65 - Skin microbes: The key to halting the allergic ma...
Atopic dermatitis (eczema or AD) is one of the first allergic conditions infants ...
Scope 65 - Global effort in the fight against cancer
Breakthroughs don’t happen in isolation. Typically, they are the steady accumulat...
Dominion Post: Malaghan Institute coming for leukaemia with ...
Disclaimer: no CAR-T cell trial is open at present. When the trial does open, we will...